missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18510968

STAT6 Antibody (STAT6/7774R), DyLight 594, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-20997DL594

Product Code. 18510968

  • € 762.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

STAT6 Monoclonal antibody specifically detects STAT6 in Human samples. It is validated for Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

STAT6
Monoclonal
DyLight 594
D12S1644, EC 2.4.1.227, EC 2.7.7.6, IL-4 Stat, IL-4-STAT, signal transducer and activator of transcription 6, signal transducer and activator of transcription 6, interleukin-4 induced, STAT, interleukin-4 induced, STAT, interleukin4-induced, STAT6B, STAT6C, transcription factor IL-4 STAT
Recombinant fragment (around aa647-847) of human STAT6 protein (exact sequence is proprietary)
0.1 mL
Apoptosis, Asthma, Cancer, Cell Biology, Epitope Tags, Immune System Diseases, Immunology, Inflammation, Phospho Specific, Signal Transduction
6778
Store at 4°C in the dark.
IgG κ
Immunohistochemistry (Paraffin)
STAT6/7774R
50 mM Sodium Borate
Rabbit
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.